GI billing is among the most complex in medicine—from screening colonoscopy conversions and endoscopy bundling rules to IBD biologic authorizations and infusion center management. MedFactor Inc delivers dedicated gastroenterology billing expertise that protects your revenue, reduces denials, and keeps your practice financially healthy.
Placeholder benchmarks representing what dedicated gastroenterology revenue cycle management can deliver when every claim is handled by specialists who understand the specialty.
From solo GI practices to multi-site digestive health systems, we deliver billing and revenue cycle management tuned to the nuances of each subspecialty.
Gastroenterology faces unique billing complexity that general medical billing companies simply cannot navigate effectively.
The most complex billing issue in GI. When a screening colonoscopy finds a polyp, it converts to diagnostic—triggering patient cost-sharing. Without modifier PT and proper documentation, patients are overcharged and practices face complaints and refunds.
Biopsy, polypectomy, and ablation codes have complex bundling rules with the base endoscopy code. General billers frequently miss add-on codes for multiple biopsies or polypectomies, losing $150-400 per procedure.
Biologics for Crohn's disease and ulcerative colitis require extensive step therapy documentation, prior authorization, and specialty pharmacy coordination. Delays cost practices thousands in infusion center downtime and lost revenue.
When a GI consult occurs on the same day as an endoscopy, modifier 25 rules are frequently misapplied. Payers routinely deny the E/M as bundled into the procedure unless separately documented medical necessity is clear.
Office-based infusion centers (POS 11) vs hospital outpatient departments (POS 19/22) have drastically different reimbursement rates. Incorrect POS coding for buy-and-bill biologics causes significant underpayment or audit risk.
Direct-acting antivirals (Mavyret, Epclusa) require fibrosis staging documentation, genotype testing, and payer-specific authorization criteria that vary widely across plans. Missing documentation delays treatment and revenue.
Our approach targets the four areas where gastroenterology practices experience the greatest financial impact.
Ensuring every billable biopsy, polypectomy, and infusion service is captured with correct add-on codes and proper endoscopy bundling.
Proactive screening colonoscopy classification, modifier PT application, and biologic authorization management to prevent denials before submission.
Staying current with colonoscopy screening mandates, biopsy bundling rules, and infusion center POS requirements to prevent audit risk.
Accelerating reimbursement through clean claim submission, rapid biologic authorization turnaround, and strategic payer escalation for GI claims.
Understanding the most common denial reasons is the first step to preventing them.
Missing modifier PT when screening converts to diagnostic, or incorrect patient cost-sharing calculation that violates ACA preventive service mandates.
Pre-submission modifier PT verification, correct screening/diagnostic classification, and patient cost-sharing calculation that protects both practice revenue and patient rights.
Biopsy add-on codes bundled into the base endoscopy code, or multiple biopsies/polypectomies undercoded as a single procedure.
Lesion-specific add-on coding for each biopsy and polypectomy, proper modifier usage for multiple procedures, and operative note documentation support.
Incomplete step therapy documentation, missing prior treatment failure records, or specialty pharmacy routing errors for IBD biologics.
Complete step therapy documentation packages, biologic authorization with clinical narratives, and specialty pharmacy coordination for seamless fulfillment.
Incorrect place of service codes for office-based infusion centers, causing underpayment or audit risk for buy-and-bill biologic claims.
Payer-specific POS verification for infusion services, correct buy-and-bill J-code billing with wastage documentation, and 340B compliance tracking.
Quick reference for the most frequently used codes in gastroenterology billing and coding.
| Code | Description | Common Use |
|---|---|---|
| 45378 | Colonoscopy, diagnostic | Diagnostic colonoscopy without biopsy or polypectomy |
| 45380 | Colonoscopy with biopsy, single/multiple | Colonoscopy with tissue sampling |
| 45385 | Colonoscopy with snare polypectomy | Polyp removal during colonoscopy |
| 43239 | EGD with biopsy, single/multiple | Upper endoscopy with tissue sampling |
| 43235 | EGD, diagnostic | Upper endoscopy without biopsy |
| 43260 | ERCP with cannulation | Base ERCP procedure |
| 43242 | EUS with fine needle aspiration | EUS-guided tissue sampling |
| 96360 | IV infusion, first hour | Initial hour of biologic infusion |
| 91164 | FibroScan transient elastography | Liver fibrosis assessment |
| 91020 | Esophageal manometry | Motility testing |
| Code | Description | Clinical Context |
|---|---|---|
| K21.0 | Gastro-esophageal reflux disease with esophagitis | GERD with esophagitis |
| K50.x | Crohn's disease (various subtypes) | IBD - Crohn's |
| K51.x | Ulcerative colitis (various subtypes) | IBD - UC |
| K80.x | Cholelithiasis (gallstones) | Gallstone disease |
| K74.x | Fibrosis and cirrhosis of liver | Liver disease |
| K58.0 | Irritable bowel syndrome with diarrhea | IBS-D |
| Z12.11 | Encounter for screening for malignant neoplasm of colon | Screening colonoscopy |
| K40-K46 | Hernias (various types) | Hernia repair |
| K59.0 | Constipation | Chronic constipation |
| B18.2 | Chronic viral hepatitis C | Hepatitis C |
| Modifier | Description | GI Application |
|---|---|---|
| PT | Colorectal screening converted to diagnostic | Used when a screening colonoscopy finds a polyp or pathology, converting it to diagnostic |
| 33 | Preventive service | Used to identify preventive screening colonoscopy services under ACA mandates |
| 25 | Significant, separately identifiable E/M service | Used when a separate office visit occurs with an endoscopy on the same day |
| 59 | Distinct procedural service | Used for multiple endoscopic procedures, EGD with ERCP, or separate biopsy sites |
| 76 | Repeat procedure by same physician | Used for repeat endoscopy on the same day |
| TC | Technical component | Used for facility billing of endoscopy or motility testing equipment |
| 26 | Professional component | Used for physician interpretation of motility studies or pathology |
| JW | Drug wastage | Used to document and bill for discarded single-use vial portions of biologics |
Prior authorization is one of the biggest revenue bottlenecks in gastroenterology. Our system eliminates the friction.
From IBD biologics and infusion therapy to advanced endoscopy and Hepatitis C treatment, every GI authorization is handled by specialists who understand the clinical criteria and payer requirements.
Complete treatment history packages including prior immunomodulator, mesalamine, and biologic failure documentation to meet payer step therapy requirements.
Pre-procedure authorization for ERCP, EUS, and EMR with clinical documentation supporting the advanced approach versus standard endoscopy.
Direct coordination with specialty pharmacies for biologic fulfillment, ensuring prior authorization matches pharmacy requirements for seamless dispensing.
Complete fibrosis staging documentation, genotype testing, and treatment history for Hepatitis C direct-acting antiviral authorization.
Identifying and plugging these common revenue leakage points can significantly improve your bottom line.
Performing multiple polypectomies or biopsies during one scope but billing only the base endoscopy code, losing $150-400 per add-on.
Infusion add-on hours (96361) going unbilled during biologic treatments, or drug wastage (JW modifier) not captured for single-use vials.
Same-day E/M services going unbilled when a separately identifiable evaluation occurs with an endoscopy, losing $75-200 per encounter.
Modifier PT not applied when screening colonoscopy converts to diagnostic, resulting in patient balance write-offs and refund processing costs.
Comprehensive revenue cycle management designed specifically for gastroenterology practices of every size and subspecialty.
Specialty-trained coders handle every endoscopy, biopsy, and infusion code with accuracy, from screening colonoscopy conversions and modifier PT to ERCP and buy-and-bill J-code billing.
Proactive screening colonoscopy defense, modifier PT documentation support, and aggressive appeals management with clinical evidence for GI claim denials.
Pre-treatment authorization for IBD biologics, Hepatitis C treatment, advanced endoscopy, and FibroScan with step therapy documentation and specialty pharmacy coordination.
Systematic accounts receivable management with prioritized follow-up on aged GI claims and strategic payer escalation to maximize recovery.
Regular coding audits with GI focus on screening colonoscopy classification, modifier PT accuracy, endoscopy bundling compliance, and infusion center POS verification.
Real-time dashboards and detailed financial reporting focused on GI KPIs including procedure-level profitability, infusion center performance, and colonoscopy conversion rates.
Our team combines deep GI billing expertise with the technology and processes to deliver consistent, measurable results for practices of every size.
See how gastroenterology-specific revenue cycle management transforms your practice's financial performance.
A structured onboarding process designed to deliver measurable improvements within the first 90 days.
Complete review of your current GI billing operations, denial patterns, coding accuracy, and revenue cycle performance baseline.
EMR integration, dedicated GI billing team assignment, workflow configuration, and payer enrollment verification.
Full billing operations begin with real-time claim submission, authorization management, and denial prevention protocols.
Performance review against baseline, workflow optimization, and documented improvement in denial rates, A/R days, and revenue capture.
How our gastroenterology-specific approach compares to in-house billing and general medical billing companies.
| Capability | In-House Team | General Billing Co. | MedFactor GI |
|---|---|---|---|
| GI-certified coders (CGSC) | ✕ | ✕ | ✓ |
| Screening colonoscopy conversion expertise | ✕ | ✕ | ✓ |
| Modifier PT and 33 documentation protocols | Inconsistent | ✕ | ✓ |
| Endoscopy add-on code capture | Inconsistent | Limited | ✓ |
| IBD biologic step therapy authorization | Manual | ✕ | ✓ |
| Buy-and-bill J-code billing with JW wastage | ✕ | ✕ | ✓ |
| Infusion center POS optimization | ✕ | ✕ | ✓ |
| Specialty pharmacy coordination | ✕ | ✕ | ✓ |
| ERCP/EUS coding expertise | ✕ | Limited | ✓ |
| Dedicated GI billing team | ✕ | ✕ | ✓ |
Discover exactly where your gastroenterology practice is losing revenue. Our no-obligation audit analyzes your coding accuracy, denial patterns, and revenue capture performance.
Real results from GI practices that partnered with MedFactor for specialty revenue cycle management.
A multi-provider GI practice with a growing infusion center was undercoding biologic infusions and missing JW wastage billing entirely. MedFactor implemented comprehensive buy-and-bill protocols and captured significant new revenue from properly coded infusion services.
A large gastroenterology group was billing only base endoscopy codes for colonoscopy and EGD procedures, missing all biopsy and polypectomy add-on revenue. MedFactor implemented add-on coding protocols that captured substantial undercoded revenue within six months.
A hepatology center faced chronic biologic authorization denials due to incomplete step therapy documentation. MedFactor's systematic authorization program transformed their approval rate and accelerated treatment initiation for HCV and IBD patients.
No matter where your gastroenterology practice operates, our team understands the payer landscape and regulatory requirements in your region.
Deep relationships and coding knowledge across Medicare, Medicaid, and all major commercial payers for GI services.
State-specific colorectal cancer screening mandate tracking, including coverage age requirements and cost-sharing protections.
Compliance tracking for 340B-covered entity infusion centers, ensuring proper drug acquisition and billing practices.
Coordination with nationwide specialty pharmacy networks for biologic fulfillment, prior authorization matching, and patient access programs.
Common questions from GI practices considering MedFactor's specialty RCM services.
This is the #1 billing issue in GI. When a screening colonoscopy finds a polyp or pathology, it converts from a preventive service to a diagnostic procedure. Our CGSC-certified coders apply modifier PT to the diagnostic code, which tells the payer that the procedure started as a screening—and under the Affordable Care Act, the patient's cost-sharing should still be based on the screening indication. General billers frequently miss this modifier, resulting in patients receiving unexpected bills and practices facing refund requests and complaints.
We integrate seamlessly with all major GI EMR platforms including gGastro (Modernizing Medicine), GI Focus, EndoWorks, ProVation, Athenahealth, and Epic. Our team also works with endoscopy reporting systems and infusion center management software to ensure complete data flow from procedure documentation to claim submission.
IBD biologic authorization is a core specialty. We compile complete step therapy documentation including prior mesalamine, immunomodulator, and biologic failures, submit authorization with clinical narratives and disease activity scores, and coordinate directly with specialty pharmacies for fulfillment. We also manage the distinction between buy-and-bill (Remicade, Entyvio) and specialty pharmacy-distributed (Humira, Stelara) biologics, ensuring proper billing pathways for each.
Buy-and-bill billing requires precise J-code selection, drug wastage documentation with modifier JW, and correct place of service coding. We bill the drug (J-code) separately from the infusion administration (96360-96365), capture all add-on hours for extended infusions, and document wastage for single-use vials. We also ensure 340B compliance for covered entity infusion centers and verify POS codes match the actual service location.
Yes, but only when the E/M represents a separately identifiable service beyond the pre-procedure and post-procedure evaluation included in the endoscopy code. This requires modifier 25 on the E/M code and documentation that clearly shows a separate evaluation for a different condition or a complex decision to perform the procedure. We train providers on documentation templates that support modifier 25, preventing bundling denials that general billers routinely accept.
Advanced endoscopy procedures have extensive add-on code families that general billers frequently miss. For ERCP, we capture sphincterotomy, stent placement, and dilation codes separately. For EUS, we ensure FNA add-on codes are billed for each lesion sampled. We also properly unbundle EGD from ERCP when both are performed at the same session, applying the correct modifiers to prevent automatic denials.
Your GI practice deserves billing partners who understand the difference between a screening and diagnostic colonoscopy—and code accordingly. Let MedFactor show you what specialty RCM can do.